The Proteasome as a Target for Cancer Treatment Christos N. Papandreou Review Article 09 August 2012 Pages: 359 - 372
Management of Diffuse Large B-Cell Lymphoma in Young Patients Michael Pfreundschuh Therapy in Practice 09 August 2012 Pages: 349 - 357
Gemcitabine In Recurrent Ovarian Cancer Jalid Sehouli Guest Commentary 10 August 2012 Pages: 345 - 346
Gemcitabine in Recurrent Ovarian Cancer M. Faruk Kose Guest Commentary 10 August 2012 Pages: 345 - 345
Gemcitabine in Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer Ramon Colomer Guest Commentary 10 August 2012 Pages: 334 - 335
Gemcitabine in Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer Carlos Delfino Guest Commentary 10 August 2012 Pages: 334 - 334
Gemcitabine in Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer Denise A. Yardley Guest Commentary 10 August 2012 Pages: 334 - 334
Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer Mario BariMario Rosario D’AndreaOrazio Vinante Original Research Article 10 August 2012 Pages: 307 - 313
Rituximab Plus Purine Nucleoside Analogs in the Treatment of Indolent Lymphoid Malignancies Tadeusz Robak Review Article 10 August 2012 Pages: 279 - 292
Pegfilgrastim James E. FramptonGillian M. Keating Adis Drug Evaluation 10 August 2012 Pages: 255 - 274
Erlotinib Dean M. RobinsonGillian M. KeatingCaroline M. Perry Adis Drug Profile 10 August 2012 Pages: 247 - 252
Cancer-related anemia Robert PirkerKatrin WiesenbergerWilma Minar Review Article 10 August 2012 Pages: 233 - 245
Front-line treatment of epithelial ovarian cancer Lainie MartinRussell J. Schilder Leading Article 10 August 2012 Pages: 221 - 231
Vaccination against cervical cancer Diane M. Da SilvaW. Martin Kast Current Opinion 10 August 2012 Pages: 207 - 219
Liposomal Doxorubicin Toni M. DandoGillian M. Keating Adis Drug Evaluation 10 August 2012 Pages: 193 - 206
Phase II Study of Pemetrexed Plus Gemcitabine in Advanced Pancreatic Cancer Hedy L. KindlerWilliam M. DuganWilliam J. John Original Research Article 10 August 2012 Pages: 185 - 191
Triptorelin in the Treatment of Prostate Cancer Chris F. Heyns Review Article 10 August 2012 Pages: 169 - 183
Evidence-Based Adjuvant Treatment of Resectable Pancreatic Adenocarcinoma Sherene LoiMichael FindlayJohn Zalcberg Review Article 10 August 2012 Pages: 159 - 168
Novel Approaches to the Management of Non-Hodgkin Lymphoma Tamara EveringtonAnthony H Goldstone Leading Article 10 August 2012 Pages: 145 - 158
Current Status and Future Prospects of Gene Therapy Karl D. LewisTahl N. HumesRene Gonzalez Current Opinion 10 August 2012 Pages: 137 - 144
The Importance of Balancing Toxicity and Efficacy in Chemotherapy Michael Boyer Review Article 10 August 2012 Pages: 127 - 136
Fluorouracil Formulations for the Treatment of Actinic Keratosis Aditya K. GuptaAndrea M. Glover Review Article 10 August 2012 Pages: 115 - 126
Current Advancements in Hard-To-Treat Cancers Christian Manegold Review Article 10 August 2012 Pages: 105 - 113
The Value of Erythropoietin Therapy in Cancer Patients Richard BootonNick Thatcher Review Article 10 August 2012 Pages: 87 - 103
Pain Control Options in Palliative Care John J. Collins Therapy in Practice 10 August 2012 Pages: 77 - 85
Neoadjuvant Chemotherapy in Bladder Cancer David J. VaughnGregory LubinieckiS. Bruce Malkowicz Current Opinion 10 August 2012 Pages: 71 - 75
Status of Newer Chemotherapeutic Strategies for the Treatment of Metastatic Gastric Cancer Gauri R. VaradhacharyChristina YuJaffer A. Ajani Review Article 09 August 2012 Pages: 65 - 70
The Role of Human Papillomaviruses in Cancer Andrea R. SpenceEduardo L. FrancoAlex Ferenczy Review Article 09 August 2012 Pages: 49 - 64
The Oral NK1 Antagonist Aprepitant for Prevention of Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy Ronald de WitPaul J. HeskethKevin J. Horgan Review Article 09 August 2012 Pages: 35 - 48
Recent Advances in the Systemic Therapy of Metastatic Colorectal Cancer Michael JeffordJohn Zalcberg Therapy in Practice 09 August 2012 Pages: 15 - 34
Chemotherapy in Locally Advanced and Metastatic Bladder Cancer Hans von der MauseLisa Sengeløv Therapy in Practice 31 December 2005 Pages: 1 - 13
Protocoles à base de gemcitabine et taxanes dans le cancer du sein Ramon Colomer Review Article 10 August 2012 Pages: 19 - 20
Chimithérapies en phase métastatique après utilisation des anthracyclines et taxanes Marc Spielmann Review Article 10 August 2012 Pages: 17 - 18
Optimisation de l’usage des taxanes en 1ère ligne de chimiothérapie Jacques Bonneterre Review Article 10 August 2012 Pages: 14 - 16
Etat des lieux de la prise en charge actuelle et intérêt polychimiothérapies dans le traitement des cancers du sein métastatiques Michel Marty Review Article 10 August 2012 Pages: 11 - 13
Evolution de la stratégie thérapeutique en situation métastatique du cancer bronchique non à petites cellules Jean-Philippe SpanoDavid Khayat Review Article 10 August 2012 Pages: 9 - 10
Place de la gemcitabine dans les traitements combinationés de radiothérapie- chimiothérapie du cancer bronchique non a petites cellules de stade III Nick Thatcher Review Article 10 August 2012 Pages: 6 - 8
Actualités sur le Pemetrexed (Alimta®) dans le Traitement des Cancers Thoraciques Maurice Pérol Review Article 10 August 2012 Pages: 13 - 19
Traitement adjusvant: bénéfice confirmé pour la chimiothérapie adjuvante à base de cisplatine dans les caners bronchiques opérés Thierry Le Chevaliere Review Article 10 August 2012 Pages: 3 - 5
Actualités sur la Gemcitabine (Gemzar®) dans le Cancer Bronchique non à Petites Cellules Pierre Fournel Review Article 10 August 2012 Pages: 9 - 12
